Galectin Therapeutics (GALT) Preferred Dividend Payments (2010 - 2026)

Galectin Therapeutics' Preferred Dividend Payments history runs 17 years deep, the most recent figure standing at $21000.0 for Q1 2026.

• On a quarterly basis, Preferred Dividend Payments rose 180.77% year-over-year to $21000.0 in Q1 2026; TTM through Mar 2026 was $185000.0, a 55.46% increase from a year earlier, with the FY2025 full-year figure at $138000.0, down 9.8% from the prior year.
• Preferred Dividend Payments eased to $21000.0 in Q1 2026 per GALT's latest filing, from $62000.0 in the prior quarter.
• Across five years, Preferred Dividend Payments topped out at $65000.0 in Q4 2022 and bottomed at -$26000.0 in Q1 2025.
• The 5-year median for Preferred Dividend Payments is $50500.0 (2025), against an average of $33062.5.
• Across the five-year window, Preferred Dividend Payments tumbled 900.0% in 2022 and surged 400.0% in 2024, its largest moves.
• Year by year, Preferred Dividend Payments stood at $65000.0 in 2022, then dropped by 3.08% to $63000.0 in 2023, then changed by 0.0% to $63000.0 in 2024, then dropped by 1.59% to $62000.0 in 2025, then plunged by 66.13% to $21000.0 in 2026.
• Per Business Quant, the three latest GALT Preferred Dividend Payments figures stand at $21000.0 (Q1 2026), $62000.0 (Q4 2025), and $39000.0 (Q3 2025).